title: An update on the use of Atripla in the treatment of HIV in the United States.
abstract: Atripla(®) (Gilead Sciences Inc, Foster City, CA, USA and Bristol-Myers Squibb, New York City, NY, USA) is a coformulated single pill composed of efavirenz, emtricitabine, and tenofovir disoproxil, intended as a once-daily potent combination antiretroviral therapeutic agent. Its efficacy is equivalent to the 3 component drugs taken in a combination as single medications. The coformulated antiretroviral regimen can be quite effective in patients whose human immunodeficiency virus is sensitive to all 3 components of Atripla. However, women at risk of pregnancy, already pregnant, or nursing mothers should not take Atripla, due to the teratogenic potential of the efavirenz moiety. Adverse effects are similar to those seen with the constituent medications, including potential central nervous system effects and renal toxicity. Since its US Food and Drug administration approval, prescriptions for Atripla have increased steadily.
authors.affiliation: HIV Interregional Initiative, Kaiser Permanente, Oakland, California, USA.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Horberg
authors.forename: Daniel B
authors.initials: DB
authors.lastname: Klein
references.citation: J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):74-8
references.pmid: 17971715
references.citation: Top HIV Med. 2009 Dec;17(5):138-45
references.pmid: 20068260
references.citation: N Engl J Med. 2006 Jan 19;354(3):251-60
references.pmid: 16421366
references.citation: AIDS. 2001 Jul 27;15(11):1369-77
references.pmid: 11504958
references.citation: J Infect Dis. 2008 Jan 1;197(1):102-8
references.pmid: 18171292
references.citation: HIV Med. 2005 Jul;6(4):284-90
references.pmid: 16011534
references.citation: J Bone Miner Res. 2004 May;19(5):714-21
references.pmid: 15068493
references.citation: J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):269-73
references.pmid: 15076241
references.citation: HIV Clin Trials. 2007 May-Jun;8(3):164-72
references.pmid: 17621463
references.citation: HIV Clin Trials. 2002 Jul-Aug;3(4):279-86
references.pmid: 12187501
references.citation: Clin Infect Dis. 2005 Jun 1;40(11):1559-85
references.pmid: 15889353
references.citation: Curr HIV/AIDS Rep. 2007 May;4(2):65-72
references.pmid: 17547827
references.citation: J Antimicrob Chemother. 2009 Nov;64(5):910-28
references.pmid: 19767318
references.citation: Clin Infect Dis. 2009 Sep 1;49(5):651-81
references.pmid: 19640227
references.citation: AIDS. 2008 Oct 18;22(16):2155-63
references.pmid: 18832879
references.citation: AIDS Patient Care STDS. 2008 Feb;22(2):99-103
references.pmid: 18260800
references.citation: AIDS Read. 2005 Jul;15(7):357-64
references.pmid: 16044577
references.citation: Antivir Ther. 2007;12(8):1165-73
references.pmid: 18240857
references.citation: J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):167-73
references.pmid: 17667331
references.citation: Drugs. 2005;65(10):1427-48
references.pmid: 15977972
references.citation: HIV Clin Trials. 2003 Nov-Dec;4(6):382-90
references.pmid: 14628281
references.citation: J Antimicrob Chemother. 2008 Oct;62(4):816-22
references.pmid: 18567912
references.citation: J Natl Med Assoc. 2009 Dec;101(12):1205-13
references.pmid: 20070008
references.citation: Drugs. 2006;66(11):1501-12; discussion 1513-4
references.pmid: 16906786
references.citation: J Clin Microbiol. 2003 Jul;41(7):3376-8
references.pmid: 12843097
references.citation: N Engl J Med. 1999 Dec 16;341(25):1865-73
references.pmid: 10601505
references.citation: J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):298-304
references.pmid: 19412117
references.citation: Am J Kidney Dis. 2002 Dec;40(6):1331-3
references.pmid: 12460055
references.citation: Clin Infect Dis. 2010 Apr 1;50(7):1041-52
references.pmid: 20192725
references.citation: Ann Intern Med. 2005 Nov 15;143(10):714-21
references.pmid: 16287792
references.citation: Nephrol Dial Transplant. 2005 Apr;20(4):743-6
references.pmid: 15741212
references.citation: Clin Pharmacokinet. 2004;43(15):1071-87
references.pmid: 15568888
references.citation: Hepatology. 2010 Jan;51(1):73-80
references.pmid: 19998272
references.citation: HIV Clin Trials. 2001 Sep-Oct;2(5):413-20
references.pmid: 11673816
references.citation: AIDS. 2009 Aug 24;23(13):1707-15
references.pmid: 19584701
references.citation: AIDS Patient Care STDS. 2005 Jul;19(7):421-4
references.pmid: 16053398
references.citation: Drugs. 2004;64(18):2075-82; discussion 2083-4
references.pmid: 15341498
references.citation: J Int Assoc Physicians AIDS Care (Chic). 2007 Sep;6(3):178-87
references.pmid: 17579126
references.citation: J Infect. 2003 Oct;47(3):262-3
references.pmid: 12963392
references.citation: JAMA. 2004 Jul 14;292(2):191-201
references.pmid: 15249568
references.citation: N Engl J Med. 2009 Dec 3;361(23):2230-40
references.pmid: 19952143
references.citation: AIDS. 2006 Mar 21;20(5):643-51
references.pmid: 16514293
references.citation: J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):163-74
references.pmid: 19357529
references.citation: J Acquir Immune Defic Syndr. 2010 Jan;53(1):62-9
references.pmid: 19838127
references.citation: AIDS. 2003 Sep 5;17(13):1925-32
references.pmid: 12960825
references.citation: AIDS Patient Care STDS. 2003 Apr;17(4):169-77
references.pmid: 12737640
references.citation: AIDS. 2004 Jan 23;18(2):351-2
references.pmid: 15075563
references.citation: HIV Clin Trials. 2001 Jan-Feb;2(1):17-21
references.pmid: 11590510
references.citation: Clin Infect Dis. 2009 Jun 15;48(12):1763-71
references.pmid: 19435436
references.citation: J Infect. 2005 Aug;51(2):E61-5
references.pmid: 16038754
references.citation: AIDS. 2002 Nov 22;16(17):2352-4
references.pmid: 12441815
references.citation: Arch Intern Med. 2010 Jan 11;170(1):57-65
references.pmid: 20065200
references.citation: J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):560-5
references.pmid: 15793366
references.citation: AIDS. 2007 Jun 19;21(10):1273-81
references.pmid: 17545703
references.citation: Ann Intern Med. 2000 Jul 4;133(1):21-30
references.pmid: 10877736
references.citation: HIV Clin Trials. 2001 May-Jun;2(3):200-4
references.pmid: 11590528
references.citation: Top HIV Med. 2003 Nov-Dec;11(6):185-98
references.pmid: 14724327
references.citation: J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):540-50
references.pmid: 17245230
references.citation: Am J Med Sci. 2003 Jun;325(6):349-62
references.pmid: 12811231
references.citation: Clin Infect Dis. 2000 Jun;30 Suppl 2:S171-6
references.pmid: 10860902
references.citation: J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1489-95
references.pmid: 15602127
references.citation: HIV Clin Trials. 2007 Jul-Aug;8(4):221-6
references.pmid: 17720662
references.citation: Infection. 2004 Oct;32(5):306-7
references.pmid: 15624898